siRNA, Anti-DGCR6L, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT51213WQ-2OMe)

The product SIRGT51213WQ-2OMe is a type of small interfering RNA (siRNA) that targets DGCR6L gene and regulates the expression of gene. The siRNA interferes with the expression of DGCR6L gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_033257.3
Alternative Names DGCR6
Related Diseases Digeorge Syndrome
Purification HPLC
Target Gene
Gene ID 85359
Uniprot ID Q9BY27
Sub Cat Target Species Modification Scale  
SIRGT52213WQ-2F DGCR6L Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT53213WQ-2MOE DGCR6L Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT54213WQ-LNA DGCR6L Human Locked Nucleic Acid (LNA) Inquiry
SIRGT51213WQ-RB DGCR6L Human Ribo-modified Inquiry
SIRGT52213WQ-BB DGCR6L Human Backbone-modified Inquiry

Related Products